title: When USP abandons drug selection, will FDA fill the void?
authors.forename: G F
authors.initials: GF
authors.lastname: Archambault
mesh_terms: D004358:Drug Therapy / Q000193:education*; D010602:Pharmacopoeias as Topic; D014481:United States; D014486:United States Food and Drug Administration